Research notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Subscribing in for the long term

Mach7 Technologies
3:27pm
February 29, 2024
M7T released its 1H24 results. No surprises here, with a recent trading update providing expectations and updated guidance following a marked shift to recurring revenues in new contracts. It’s clear to us that the company continues to see this trend play out in its contract pipeline, and a trend which we view will result in a more sustainable and investor friendly business model. No changes to our forecasts and we continue to see significant upside potential in the name. M7T remains one of our key picks within the space.

1H24 result: Giddy up

Percheron Therapeutics
3:27pm
February 29, 2024
PER has reported its 1H24 results. No surprises here given quarterly updates. Cash balance remains the major key metric, which is sufficient to fund PER until the Ph2b topline outcome at the end of the year. Focus remains solely on near-term catalysts including recruitment milestones, toxicology study, and Ph2b top-line results due to read out by the end of the year. No changes to our valuation which remains A$0.23 p/s. We view PER as having one of the best risk/return profiles in the space with clear near-term catalysts, strong board and management team, and scientific support for success.

Profitable growth expected for FY24

MedAdvisor
3:27pm
February 29, 2024
MDR reported its 1H24 result which was in line with pre-released update, with revenue up 18% and EBITDA up 21%. Management is guiding to profitability for FY24. The investment into the UK is completed and the transition to a SaaS platform is complete. In addition MDR will invest A$10m to A$15m to build out a shared service structure, looking to optimise a cloud native platform with the aim of reducing operating costs over time.

Approaching start of clinical trial

Tissue Repair
3:27pm
February 28, 2024
TRP posted its 1H24 result with a net loss of $2.3m, finishing the period with sufficient capital to fund its clinical program. TRP expects the Phase 3 trial for venous leg ulcers (VLU) to start recruiting in 1Q25 which is a slight delay from the last update (was 4Q24) and top-line results to be reported late CY25. The National Institute of Health estimates the cost of treating VLUs in the US at between US$2.5bn and US$3.5bn pa. The cosmetic gel product, TR Pro+, was successfully launched, with initial feedback positive. TRP will continue to drive increased awareness as well as explore potential partnership and distribution opportunities.

Offsetting the cycle with acquisitions

Peter Warren Automotive
3:27pm
February 28, 2024
PWR reported NPBT -20% on the pcp, with the core business (ex-acquisition) down ~30%. Heightened operating and funding costs dragged on the half. The order book closed flat over the half, however down ~25% from the July-23 acquisition position. Orders have remained solid and broadly in-line with deliveries. PWR expects continued revenue growth, however new car margins to ‘taper’. PWR’s ROS margin dropped to 2.9% in 1H24 and we expect further compression. PWR’s balance sheet remains in a position to continue to execute on its consolidation strategy. However, the cyclical margin and structural cost impacts have been clear in this result and we expect earnings to continue to decline. Whilst we view PWR as relatively cheap (on 9x PE), we expect it will be difficult to re-rate against the negative earnings trajectory. We move to Hold.

Heading in the right direction

Flight Centre Travel
3:27pm
February 28, 2024
FLT’s headline result was stronger than we expected. Adjusting for items which are now reported below the line, the result was just below our forecast but was materially below consensus given it underestimated FLT’s seasonal earnings skew. Importantly, the core business units (Corporate and Leisure) both beat our forecast and their margins are scaling nicely. FLT is well on track to deliver its FY24 guidance. We have made double digit upgrades to our NPBT forecasts given the non-cash amortisation on the convertible notes (CN) will be reported below the line (like WEB) and it has paid off ~A$250m debt and bought back A$84m of CN. For these reasons and given FLT’s margins will continue to improve, we now have more confidence in it achieving its 2% margin target. We assume this is achieved in FY26 vs FLT’s aim of FY25. We think today’s share price weakness is overdone and represents a great buying opportunity. Trading on an FY25 PE of 13.3x, we reiterate our Add rating.

Building on its strong market ties

Woodside Energy
3:27pm
February 28, 2024
A strong CY23, with underlying EBITDA/NPAT ahead of consensus by +1%/+9%. An equally strong final dividend of US60 cents (vs VA/MorgansF US/40 cents). This was supported by the recent news that WDS had agreed to sell down a 15% stake in the Scarborough field to JERA, with a Heads of Agreement for 0.4mtpa of LNG. Analyst roundtable focused on modelling and understanding the Scarborough deal. We maintain an Add rating, with a A$34.20 target price (was A$34.30).

1H24 result: Focusing on integration

Avada Group
3:27pm
February 28, 2024
In 1H24 AVD delivered LFL revenue and EBITDA growth of 4% and 6%, respectively. Group underlying NPATA was up 19.3% to A$3.2m. Margins held steady hoh (GM +60bps; EBITDA -60bps) and were up strongly on the pcp (GM +300bps; EBITDA margin +130bps). Integration of recent acquisitions (STA and Wilsons); cost control; operational efficiencies; and delivery of a strong pipeline of projects remains the focus. AVD’s FY24 underlying EBITDA guidance of A$20-22m (excluding STA) was last reaffirmed at its AGM (Nov-23). Annualised 1H24 group EBITDA is currently running at ~A$18.5m. AVD intends to declare a FY24 full year dividend (subject to maintaining current trajectory and cash flow conversion).

Executing well on the controllables

Kina Securities
3:27pm
February 28, 2024
KSL’s FY23 Net Profit Before Tax (PGK 175m) was +18% on the pcp and +3.5% above MorgansE. KSL’s FY23 underlying NPAT (PGK105m) was in-line with the pcp (impacted by the lift in the tax rate on PNG banks to 45% from 30%), and ~+10% above MorgansE This was broadly a good result by KSL, in our view.  Management delivered ~+20% underlying PBT growth in a more difficult net interest margin environment, with costs and bad debts being well contained. We lift our KSL FY24F/FY25F EPS forecasts by ~4%-7% on higher non-interest income and reduced cost estimates. Our target price rises to A$1.24 (previously A$1.14). KSL continues to deliver solid underlying profit growth, and trading on ~5x FY24F EPS and a >10% dividend yield, we see the stock as too cheap. ADD. We lift our KSL FY24F/FY25F EPS forecasts by ~4%-7% on higher non-interest income and reduced cost estimates. Our target price rises to A$1.24 (previously A$1.14).

Shifting gears for the new route ahead

Motorcycle Holdings
3:27pm
February 28, 2024
MTO delivered 1H24 EBITDA (pre-AASB) of A$14.2m (guidance A$14-16m); and NPAT of A$6.6m (-37% on the pcp; and -47% hoh; and -6% vs MorgansF). LFL comps vs pcp: sales -7%; GP -11%; Opex -2%; EBITDA (post-AASB) -30%; and Underlying EBITDA (pre-AASB) -%. Encouragingly, MTO pointed to improving trade through Jan-Feb; continued to grow its market share of new motorcycles (~15% in 1H24); expand its product range (CFMOTO); and will benefit from a seasonally stronger 2H within Mojo. We recently moved to a Hold recommendation given limited earnings visibility and lower confidence in the near-term outlook. While we expect improved operating performance in 2H24, we prefer to wait for greater evidence of earnings certainty before considering a more positive view.

News & insights

A detailed comparison of US productivity and global growth forecasts, highlighting key differences with Australia.

Why The US Has Higher Productivity

Good morning. Today I want to talk about the U.S. economy in comparison, to other economies and, why it's performing, the way it is. The documents I will refer to are first the IMF, outlook, which is,  come out in the last two weeks.  That gives us some international comparisons.

For the US economy I use, the monthly outlook from Standard and Poor's, which is, the number one rated by the Congressional Budget Office, well ahead of other economic forecasters. For the US economy, both the IMF and, Standard Poor's agree that growth this year should be 2%. Our own model of the US economy, based on the Chicago Fed National Activity Indicator, is also forcasting US growth of 2%.

Still, that's 2% is less whatever the negative effect is from, from the US shutdown. When the shutdown continues for a month, that growth rate falls from 2% down to about 1.8 % 1.7%. So it's a moderate slowdown. Still growth in the U.S. economy accelerates next year to about 2.2%. I'll talk later on where that growth is coming from.

When we look at growth in other areas we see that: Euro area is miserable. Great Britain is growing faster than the Euro area now. This year the UK should grow by 1.3% but, the Euro area should grow by about 1.2% this year. Euro area growth drifts off to an even more miserable 1.1% next year. But fortunately, that generates a lot of savings to invest in other countries like us. Those savings then go in to the US equities and bond markets and, the Australian stock market and places like that.

China is slowing down to 4.8% this year and 4.2% next year according to the, IMF. Still, heroically India, marches on to 6.6% growth this year and 6.2% next year. For emerging markets, which include the Indo Pacific generally ,Growth is proceeding  at about 5.2% this year and 4.7%, next year.

The U.S is still, pretty good in comparison. This year, it's, growing at 2% or, depending on  the results of the shutdown. Next US Growth accelerates, to 2.2%, and growth is then about the same the year after.

There's been a lot of debate this year about the effect of tariffs on the US inflation.  In spite of higher tariffs , US inflation is stubbornly , stubbornly low. Headline inflation, which includes food and energy this year should be only 2.8%. Hardly something to scare markets. And that continues a 2.9% next year and 2.5% the year after. Amazingly,US  core inflation is a bit higher than that 3% this year and 3.3% next year. It's just that food and energy prices are falling in the US. Why can't that happen here?

Lets look at one of the reasons that you get really quite steady growth and relatively low inflation in the US The comparison I want to make here is between US output per hour and Australian output per hour. In the beginning of this year, we had a shocking slowdown in productivity growth because our government decided that was better to hire more, people from the public service than generate employment in the private sector. It is well known that, productivity in the market economy grows much faster than in the, than in the public sector. So,  for the first quarter, productivity in Australia grew, or  output per hour worked per annum ,grew by 0.3%  . The RBA has told us that, they expect output per hour that will rise to about 0.7%per annum , the same as the UK. And we'll be able to maintain productivity growth rate of 0.7%, going forward.

Let's compare that to what's happening in the US economy. This year It looks like the US will be producing labour productivity much higher than the Australia.  US Output per hour should grow by 1.6% this year . Next year US Output per hour may grow  even more by, 2.1%. Following that US labour productivity the year should grow between 1.6 and 1.7%,. This is  full 1% faster than, the Australian economy is expected to grow in terms of productivity. Remember, it's growth and productivity which generates increase in living standards.

There's two reasons, that we can provide for why the U.S., productivity is growing so much faster than ours. One is a flexible labour market. It's an extremely flexible labour market in the US. The current Australian government has made our labour market less flexible, less than it previously was. A second reason is deregulation . The program of deregulation by the US administration is making it easier for business , to do business.

That, of course, in turn generates higher levels of business investment. That higher level of business investments creates more growth. So, it's a series of policies which are different in each country . The result will be that, living standards in, in the U.S are going to start going to be growing significantly faster than they are in Australia.

And that's the end of the good news for the day.

Read more
Australia's trimmed mean inflation hit 3%, driven by surging electricity prices and the end of federal subsidies, signalling the end of the rate-cut cycle.

Last time I spoke to you about Australian inflation and its effect on what the RBA might do in its November meeting, I said that expectations for inflation for the year to September, which would be published in October, were between 2.5% and 2.7%. I also said that if inflation came in at the lower estimate of 2.5%, then we could see a rate cut in November.

Well, the numbers are out, and unfortunately, not only are we not getting a rate cut in November, it’s unlikely we’ll see another rate cut any time soon. In fact, it’s fair to say we may be at the very end of the rate-cutting cycle in Australia. The reason is that the core measure, the trimmed mean, which is the RBA’s preferred measure of underlying inflation, came in not at 2.5%, not at 2.6%, and not even at 2.7%, but at a shockingly high 3%.

This result was driven by a 1.3% increase in prices in the previous quarter, which annualises to about 5%, a surprise that wasn’t anticipated. Looking deeper into the quarterly CPI, we saw housing prices rising at 4.7%, health costs up 4.2%, and education costs increasing by 5.3%.

The ABS has indicated that the major source of inflation was a jump in goods inflation, which rose 3%, up 1.1% from the previous quarter, or 4.4% annualised. The standout contributor was electricity, which saw a massive year-on-year increase of 23.6%. Other household fuels actually fell by 1.6%, and annual services inflation was 3.5%.

The ABS attributed this unexpected rise in inflation primarily to electricity prices. But it’s not just electricity prices themselves, it’s the end of Federal Government funding to the states that had been keeping those prices low.

The ABS reported that electricity prices rose 23.6% over the past 12 months, largely because State Government rebates, funded by the Commonwealth under the Energy Bill Relief Fund, have now been used up. These rebates included Queensland’s $1,000 rebate, Western Australia’s $400 rebate, and Tasmania’s $250 rebate. With these rebates exhausted, electricity prices have surged.

The A

BS data shows electricity prices excluding government rebates, and highlights the impact of the federal funding. Electricity prices really took off in 2023, rising by almost 20%, which posed a political risk for the Federal Government. In response, the Government provided funding to State Governments to suppress those prices. There were schemes in both 2023 and 2024, and ahead of the last election, the subsidised price paid by consumers dropped to around 80% of the original cost, well below the actual cost of generation.

However, since December 2024, those subsidies have been reduced. Over the past year, prices have climbed again, though they remain below the unsubsidised cost, which is now around 122% of the original price, or about a quarter higher than where things stood in 2023.

The result of all this is 3% core inflation. If inflation had come in at 2.5%, rates could have fallen from 3.6% to 3.35%. But with 3% core inflation, rates should need to rise by 25 basis points. That said, we’re likely at the end of the rate-cut cycle.

Is the RBA likely to raise rates? They might consider it, but this is cost-push inflation, not demand-driven inflation, so increasing rates wouldn’t help. It would only worsen the situation. This very high inflation figure, driven by the end of federal electricity subsidies, signals the end of the current series of Australian rate cuts.

Read more
Receiving a large inheritance can be life-changing, but it also comes with important financial decisions.

Key Takeaways

  • Press pause. Park funds safely while you confirm what you received, obligations, and any tax implications.
  • Build a plan that fits your goals and timeframes. Prioritise cash buffers, debt decisions, investing, super, and estate wishes.
  • Get advice early. A financial adviser and tax accountant can help you avoid costly mistakes and set up a long-term strategy.
  • Use professional inheritance financial advice to align tax, super, investing, and estate planning decisions.

Receiving a large inheritance can be life-changing. It can also feel overwhelming. The right first steps help you protect capital, make clear decisions, and turn a windfall into lasting financial security. This guide walks you through a practical process Morgans advisers use with clients every day, with a focus on inheritance financial advice tailored to Australian rules.

Step 1: Pause and assess your situation

Before making big choices, slow down.

  • List the assets you have inherited: cash, property, superannuation, shares, term deposits, insurance proceeds, or a business interest.
  • Confirm control and timing. Has probate been granted? Are there executor timelines or sale constraints?
  • Check any liabilities. Some assets may come with debts, fees, rates, or ongoing costs.
  • Gather documents. Will, probate, estate distribution statement, title records, super death-benefit statements, cost-base records for property and shares.

Short term, consider holding funds in high-interest savings or term deposits while you complete the groundwork. ASIC’s Moneysmart has clear tips on handling large amounts of money.

Step 2: Understand the emotional impact

An inheritance often follows the loss of a loved one. It is normal to feel pressure to act quickly. Give yourself time.

  • Avoid large purchases until you have a plan.
  • Set simple rules. For example, no irreversible decisions for 30 to 90 days.
  • Write down your goals and values. What will this money do for you, your family, or future generations?
  • If you feel rushed by offers or schemes, step back and check for red flags. Scamwatch has practical guidance.

Step 3: Map your goals and timeframes

Your strategy should mirror when you will need the money.

  • 0 to 2 years (short term): capital protection and liquidity. Cash, term deposits, or an offset account.
  • 3 to 7 years (medium term): a diversified mix of income and growth.
  • 7 years plus (long term): growth-focused assets with disciplined risk management.

Align each dollar with a job: emergency fund, debt choices, home or investment property plans, children’s education, retirement savings, or charitable giving.

Step 4: Tax and rules to consider

Australia has no inheritance or estate tax. You can still face tax on income or gains from inherited assets. Seek written advice before selling or restructuring. 

  • Property. Capital Gains Tax (CGT) can apply when you sell. A main-residence exemption may be available in some cases and there is a two-year timing rule, with possible extensions in limited circumstances. The ATO has more information on extensions to the 2-year ownership period.
  • Shares and managed funds. You usually inherit the deceased’s cost base. Future gains or income may be taxable in your hands.
  • Superannuation death benefits. Tax depends on your relationship to the deceased and the components of the benefit. ATO guidance explains who counts as a dependant and how tax is applied.
  • Pension and benefits. A large inheritance can affect Centrelink assessments under the income and assets tests. Check how your position may change.

Step 5: Build a financial strategy

This is where professional inheritance financial advice makes a clear difference. A tailored strategy can help you:

  • Preserve capital while generating reliable income.
  • Create an optimised tax position.
  • Invest based on your risk profile and timeframes.
  • Plan for retirement or intergenerational goals.

Common strategies include:

  • Diversified portfolios. Combine cash, fixed income, Australian and global shares, property, and alternatives.
  • Superannuation contributions. Use concessional and non-concessional contributions where appropriate, subject to caps and personal circumstances.
  • Debt reduction or offset use. Compare the after-tax, after-fee return from investing with the guaranteed saving from reducing non-deductible debt.
  • Property investment. Weigh cash flow, rates, maintenance, tenancy risk, and diversification.
  • Philanthropy. Structured giving can align with your values and tax planning.

Step 6: Make considered debt decisions

A lump sum tempts quick mortgage paydowns or new borrowing. Test options with advice.

  • Offset first. Parking cash in an offset account can cut interest while keeping flexibility.
  • Compare outcomes. Paying down non-deductible debt is often strong, but do not drain all liquidity.
  • Avoid new lifestyle debt. Large purchases can wait until your plan is set.

Step 7: Invest with discipline

Good portfolios are simple, diversified, and low friction.

  • Use broad market building blocks supported by high-quality research.
  • Keep fees and taxes in focus.
  • Rebalance periodically to maintain your risk level.
  • Document an investment policy statement you can stick to when markets move.

Step 8: Update your own estate plan

An inheritance is a prompt to review your legal documents.

  • Update your will and enduring powers if your situation has changed.
  • Review super nominations and life insurance beneficiaries.
  • Consider a testamentary trust if suitable for family protection or flexibility.

Learn more about Estate Planning with a Morgans adviser.

Step 9: Avoid common mistakes

Many Australians make avoidable errors with inherited wealth, such as:

  • Making large purchases without a plan
  • Ignoring tax consequences when selling assets
  • Failing to diversify or taking concentrated bets
  • Chasing high returns promised by unlicensed operators
  • Not seeking professional advice early enough

Use checklists, document your decisions, and keep a record of key statements and dates.

Step 10: Work with a Morgans financial adviser

Every inheritance is unique, and so is your financial journey. A Morgans adviser can help you:

  • Clarify goals, timelines, and trade-offs
  • Model debt vs invest decisions
  • Design a diversified portfolio to suit your risk profile
  • Coordinate with your accountant and solicitor on tax and estate matters
  • Set up a review rhythm so your plan stays on track

Contact us today for a free consultation with a Morgans adviser. Let us help you turn your inheritance into long-term financial security.

Learn more with our superannuation advice, financial planning, retirement and estate planning

      
Contact us
      

Frequently asked questions

1) Do I pay tax on inherited money in Australia?
There is no inheritance or estate tax. You may still pay tax on income or gains from inherited assets. CGT can apply if you sell property or shares you inherited. Tax may apply to some superannuation death-benefit payments depending on your relationship to the deceased and the components of the benefit.

2) Should I pay off my home loan or invest the inheritance?
It depends on interest rates, risk tolerance, cash flow, and timeframes. Many clients park funds in an offset account first, then decide with advice. Compare the saving from reducing non-deductible debt with the expected after-tax return from investing. A written plan helps you commit to the path you choose.

3) What if I inherit a house?
Decide whether to live in it, rent it, or sell. Each option has different tax, cost, and lifestyle impacts. Keep records of valuations, costs, and dates. Speak to your adviser and tax specialist before you sign a contract. ATO guidance covers CGT rules and timing, including the two-year rule and limited extension grounds.

4) Who should I talk to first?
Start with a licensed financial adviser and a tax accountant. If property or complex structures are involved, engage a solicitor. Your financial adviser can coordinate the team and build a step-by-step plan. 

Read more